← All companies

CABA

Cabaletta Bio, Inc.

CABA Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$2.77

+0.08 +2.97%

Key statistics

from XBRL data in SEC filings

Market cap

$452M

Revenue (TTM)

—

Net income (TTM)

-$175M

EPS (TTM)

$-1.78

P/E ratio

—

Dividend yield

—

Free cash flow

-$132M

Cash

$117M

Total assets

$148M

Gross margin

—

52-week range

$1.26 – $4.23

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Amended charter or bylaws; Shareholder vote results Jun 11, 2026 8-K Regulation FD disclosure; Other events Jun 3, 2026 10-Q Quarter ended 2026-03-31 May 14, 2026 8-K Results of operations (earnings release) May 14, 2026 8-K Regulation FD disclosure; Other events May 14, 2026 8-K Entered a material agreement; Results of operations (earnings release); Other events May 4, 2026 8-K Other events May 4, 2026 8-K Other events Apr 20, 2026 10-K Fiscal year ended 2025-12-31 Mar 23, 2026 8-K Results of operations (earnings release); Regulation FD disclosure Mar 23, 2026 8-K Regulation FD disclosure; Other events Jan 12, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Other events Oct 29, 2025 8-K Regulation FD disclosure; Other events Oct 27, 2025 8-K Regulation FD disclosure; Other events Oct 9, 2025 8-K Regulation FD disclosure Sep 3, 2025 10-Q Quarter ended 2025-06-30 Aug 7, 2025 8-K Results of operations (earnings release) Aug 7, 2025 8-K Entered a material agreement; Other events Jun 12, 2025 8-K Terminated a material agreement; Regulation FD disclosure; Other events Jun 11, 2025 8-K Amended charter or bylaws; Shareholder vote results Jun 10, 2025 8-K Director or officer change May 19, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Results of operations (earnings release); Regulation FD disclosure May 15, 2025 10-K Fiscal year ended 2024-12-31 Mar 31, 2025 8-K Results of operations (earnings release) Mar 31, 2025 8-K/A Regulation FD disclosure; Other events Feb 18, 2025 8-K Regulation FD disclosure; Other events Feb 18, 2025 8-K Results of operations (earnings release); Regulation FD disclosure; Other events Jan 13, 2025 8-K Regulation FD disclosure; Other events Nov 18, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Results of operations (earnings release) Nov 14, 2024 8-K Regulation FD disclosure; Other events Oct 7, 2024 8-K Entered a material agreement Sep 30, 2024 10-Q Quarter ended 2024-06-30 Aug 8, 2024 8-K Results of operations (earnings release); Regulation FD disclosure Aug 8, 2024 8-K Regulation FD disclosure; Other events Jun 14, 2024 8-K Shareholder vote results Jun 4, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024